SoCal Tech Calendar

MAY 14, 2010

Thursday, May 20, 2010 -- UCI TechPortal Event. Marc Averitt, Okapi Venture Capital; Douglas Crawford, QB3 Garage; Michael Guiliana, Knobbe Martens; Stephen Jenks, UCI/Hiperwall; Matthew Jenusaitis, OCTANe; and Jacob Levin, UCI. Speakers include B. See [link] (more).

UCI 100

UCI OCTANE Incubator Mentor 100

SoCal Tech Calendar

JANUARY 23, 2013

Thursday, January 24, 2013 -- Venture Capital Process and Trends. UCI Chief Executive Roundtable. Holmen, Managing Director, Miramar Venture Partners on "Venture Capital Process and Trends". See [link] (more)

Venture Capital 113

Venture Capital Capital UCI Miramar 113

SoCal Tech Calendar

JUNE 22, 2017

This technology preview is geared for Serial Entrepreneurs, Angel Investors, and Venture Capital Investors. Over 40 presentations from our region's most prominent research institutions: Caltech, USC, UCLA, UCSB, UCI, Childrens Hospital LA, University of Hawaii, Arizona State University, LA BioMed, and CalState LA! See [link] (more)

LAVA 100

LAVA UCI CalTech USC 100

SoCal Tech Calendar

JANUARY 18, 2012

Managing Director, Incubic Management (a venture capital fund in Mountain View, CA). Tuesday, January 24, 2012 -- Milton Chang, Ph.D., Entrepreneurship Course, 2012 Guest Speaker Lectures, Henry Samueli School of Engineering, UC Irvine. Free and open to the public.

Incubator 113

Incubator UCI Course Venture Capital 113

SoCal Tech Calendar

JUNE 22, 2017

This technology preview is geared for Serial Entrepreneurs, Angel Investors, and Venture Capital Investors. Join us at Cal State Los Angeles for a full day of innovations and technologies presented by the region's finest researchers and inventors!

LAVA 100

LAVA UCI CalTech UCLA 100

socalTECH

FEBRUARY 5, 2009

Two UC Irvine Students, Kyle Good and Bryan Le, have scored $25,000 from the X PRIZE Foundation and Prize Capital, in a competition which invited ideas for green energy projects for the group.

UCI 124

UCI Competition Ideas Report 124

socalTECH

OCTOBER 31, 2012

Thesan is headed by Gordon Foulkes, and said it has licensed its products from the University of California, Irvine, out of the laboratory of Professor Daniele Piomelli, who is Louise Turner Arnold Chair of Neurosciences at UCI. Foulkes is the former CEO of Excaliard Pharmaceuticals (acquired by Pfizer) and also served at RiverVest Ventures.

UCI 147

UCI San Diego Funding Product 147